Table 1.
Characteristic | Subgroup | Total NEN (n = 181, %) | NEC (n = 152, %) | NETG3 (n = 29, %) |
---|---|---|---|---|
Age | ||||
<50 | 13 (7) | 9 (5.9) | 4 (13.8) | |
50–59 | 20 (11.6) | 18 (11.8) | 2 (6.9) | |
60–69 | 64 (35.4) | 55 (36.2) | 9 (31) | |
70+ | 84 (46.4) | 70 (46.1) | 14 (48.3) | |
Sex | ||||
Male | 109 (60.2) | 94 (61.8) | 15 (51.7) | |
Female | 72 (39.8) | 58 (38.2) | 14 (48.3) | |
Site | ||||
Right colon | 38 (21) | 36 (23.7) | 2 (6.9) | |
Rectum | 37 (20.4) | 36 (23.7) | 1 (3.4) | |
Esophagus | 19 (10.5) | 18 (11.8) | 1 (3.4) | |
Gastric | 17 (9.4) | 16 (10.5) | 1 (3.4) | |
Unknown | 25 (13.8) | 19 (12.5) | 6 (20.7) | |
Pancreas | 25 (13.8) | 13 (8.6) | 12 (41.4) | |
Left colon | 10 (5.5) | 9 (5.9) | 1 (3.4) | |
Gallbladder/duct | 3 (1.7) | 3 (2) | 0 (0.0) | |
Other | 3 (1.7) | 2 (1.3) | 1 (3.4) | |
Small bowel | 4 (2.2) | 0 (0.0) | 4 (13.8) | |
Cell type | ||||
Large cell | 87 (57.2) | |||
Small cell | 65 (42.8) | |||
Ki-67 | ||||
21–55% | 36 (19.9) | 13 (8.6) | 23 (79.3) | |
>55% | 132 (72.9) | 130 (85.5) | 2 (6.9) | |
>20% (exact value not specified) | 13 (7.2) | 9 (5.9) | 4 (13.8) | |
Surgery of primary tumour | ||||
Resected (prior to sampling) | 59 (32.6) | 50 (32.9) | 9 (31) | |
Not resected | 122 (67.4) | 102 (67.1) | 20 (69) | |
Disease | ||||
Non-metastatic (stage I–III) | 36 (19.9) | 31 (20.4) | 5 (17.2) | |
Metastatic (stage IV) | 145 (80.1) | 121 (79.6) | 24 (82.8) | |
Smoking habit | ||||
Smoker | 37 (20.4) | 33 (21.7) | 4 (13.8) | |
Ex-smoker | 54 (29.8) | 45 (29.6) | 9 (31) | |
Non-smoker | 73 (40.3) | 60 (39.5) | 13 (44.8) | |
Unknown | 17 (9.4) | 14 (9.2) | 3 (10.3) |